harnessing the predictive power of blood-based small RNAs
company
Hummingbird extracts deep insights into disease through the integrated analysis of both disease and immune system derived small RNA biomarkers from whole blood.
This dual interrogation of signal from disease and the host response to disease enables a highly sensitive, robust, and AI powered platform that will revolutionize how we diagnose, treat, and manage cancer and other diseases.
The privately held company is based in Heidelberg, Germany.
developing novel small RNA blood tests
to improve human health
We are Hummingbird Diagnostics
Hummingbird’s dedicated and experienced team is committed to delivering results for patients.
We have developed best-in-class expertise in processing and analyzing blood-borne small RNAs with a proven track record in molecular diagnostics, clinical laboratory sciences, computational biology as well as in statistical machine learning and artificial intelligence.
our clinical partners - valued contributors to our success
partners
a team of skilled and motivated scientists, physicians, engineers and professionals
join us
Our success rests upon a strong team!
Currently, there are no positions available.